Michel Darnaud
Chief Executive Officer at STENTYS
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Vance Brown | M | 54 | 23 years | |
| Jonathan W. Chen | M | 49 |
MicroPort Cardiac Rhythm Management International Ltd.
 MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | 5 years |
| Betty Tsai | F | 51 |
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | - |
| Lauren Tengler | F | - | 24 years | |
| Benoît Clinchamps | M | 58 |
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | 4 years |
| John Sorenson | M | 56 | 22 years | |
| Chien Cheng Lin | M | 53 |
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | - |
| Tom Coles | M | - | 10 years | |
| Alex Shvartsburg | M | 54 | 7 years | |
| Christian M. Spaulding | M | 68 | 7 years | |
| Francesco Bianchi | M | 66 | 9 years | |
| Sharon O'Kane | M | 56 | 9 years | |
| Marie Meynadier | M | 63 | 10 years | |
| Philippe Wanstok | M | - |
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | 7 years |
| Gilles Montalescot | M | - | - | |
| Vincent Leveaux | M | 49 |
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | 16 years |
| Wendy Carruthers | F | 55 | 20 years | |
| Xiao Huang | M | 39 |
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | 4 years |
| Patrick Serruys | M | - | - | |
| Thierry Lefèvre | M | - | - | |
| Raoul Bonan | M | - | - | |
| Xin Sun | M | 43 |
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | 4 years |
| Colin Morrison | M | - | 22 years | |
| Paul Vodden | M | 58 |
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | - |
| Marco Gario | M | - | 13 years | |
| Julien Dolivet | M | - |
Physidia SAS
 Physidia SAS Miscellaneous Commercial ServicesCommercial Services Physidia SAS is a research and French development company that specializes in physical and natural sciences. The company was founded in 2010 and is based in Saint-Barthelemy d'Anjou, France. | 1 years |
| Alain Delabost | M | - | 6 years | |
| Qi Yi Luo | M | 62 |
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | 4 years |
| Milad Girgis | M | - | 20 years | |
| Deanna Wilke | F | - | 8 years | |
| Yin Shan Hui | F | 56 |
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | 1 years |
| Xiao Ming Zhu | M | 56 |
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | 10 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Arthur Rosenthal | M | 77 | 19 years | |
| James Tobin | M | 79 | 10 years | |
| Marco Dolci | M | 62 | 6 years | |
| André Lerebours | M | - | 3 years | |
| Damien McDonald | M | 59 | 7 years | |
| Brian Burns | M | 60 | - | |
| Philippe J. C. Gastone | M | 69 |
Ceragenix Pharmaceuticals, Inc.
 Ceragenix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ceragenix Pharmaceuticals, Inc. operates as a biopharmaceutical company. It focuses on infectious disease and dermatology. It offers two base technologies: Ceragenins and Barrier Repair. The Ceragenins is used for the treatment of infectious disease and Barrier Repair Technology is used for the treatment of dermatological disorders, including atopic dermatitis, neonatal skin disorders and others. The company was founded in 2002 and is headquartered in Denver, CO.
OnSource Corp.
École des Hautes Études Commerciales de Paris
| 10 years |
| Gonzague Issenmann | M | 51 | 10 years | |
| Alberto Bautista | M | 72 |
Ceragenix Pharmaceuticals, Inc.
Ceragenix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ceragenix Pharmaceuticals, Inc. operates as a biopharmaceutical company. It focuses on infectious disease and dermatology. It offers two base technologies: Ceragenins and Barrier Repair. The Ceragenins is used for the treatment of infectious disease and Barrier Repair Technology is used for the treatment of dermatological disorders, including atopic dermatitis, neonatal skin disorders and others. The company was founded in 2002 and is headquartered in Denver, CO.
OnSource Corp.
| 5 years |
| Cheryl A. Hoffman-Bray | F | 66 |
OnSource Corp.
Ceragenix Pharmaceuticals, Inc.
Ceragenix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ceragenix Pharmaceuticals, Inc. operates as a biopharmaceutical company. It focuses on infectious disease and dermatology. It offers two base technologies: Ceragenins and Barrier Repair. The Ceragenins is used for the treatment of infectious disease and Barrier Repair Technology is used for the treatment of dermatological disorders, including atopic dermatitis, neonatal skin disorders and others. The company was founded in 2002 and is headquartered in Denver, CO. | 5 years |
| Clifford L. Neuman | M | 75 |
OnSource Corp.
| - |
| David B. Milne | M | 61 | 6 years | |
| Jacques Séguin | M | - | 7 years | |
| Andrea Saia | F | 66 | 7 years | |
| Dianne Blanco | F | 77 | 2 years | |
| Carl Genberg | M | 72 |
Ceragenix Pharmaceuticals, Inc.
Ceragenix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ceragenix Pharmaceuticals, Inc. operates as a biopharmaceutical company. It focuses on infectious disease and dermatology. It offers two base technologies: Ceragenins and Barrier Repair. The Ceragenins is used for the treatment of infectious disease and Barrier Repair Technology is used for the treatment of dermatological disorders, including atopic dermatitis, neonatal skin disorders and others. The company was founded in 2002 and is headquartered in Denver, CO.
OnSource Corp.
| 5 years |
| Thierry Sommelet | M | 54 | - | |
| Michael Berman | M | 66 | 5 years | |
| Stefano Gianotti | M | 61 | 3 years | |
| Maulik Nanavaty | M | 62 | - | |
| Sophie Baratte | M | 61 | 4 years | |
| Vivid Sehgal | M | 56 | 2 years | |
| Christophe Lottin | M | - | 3 years | |
| Roy Khoury | M | 50 | 6 years | |
| Kristen Ambrose | F | 47 | 18 years | |
| Michael D. Lesh | M | 69 | 8 years | |
| Karen M. King | F | - | 2 years | |
| Steven S. Porter | M | 73 |
OnSource Corp.
| - |
| Frank L. Jennings | M | 73 |
OnSource Corp.
| 4 years |
| John Onuscheck | M | 57 | - | |
| Ernest Mario | M | 85 | 15 years | |
| Uwe E. Reinhardt | M | 87 | 13 years | |
| Hugh M. Morrison | M | 77 | 6 years | |
| André-Michel Ballester | M | 65 | 1 years | |
| Mary E. Russell | M | 68 | 6 years | |
| Rosario Bifulco | M | 69 | - | |
| Alfred Novak | M | 76 | 7 years | |
| Jeffrey S. Sperber | M | 59 |
OnSource Corp.
| - |
| Morten C. Nielsen | M | 68 | 5 years | |
| Edward Randolph | M | 66 | 4 years | |
| Nancy Lelicoff | F | - | 4 years | |
| James H. Taylor | M | 84 | - | |
| Jeffrey Harold Goodman | M | 75 | 9 years | |
| Ray J. Groves | M | 88 | 12 years | |
| Stephen Keaney | M | 61 | 4 years | |
| Randy Nuernberg | M | - | 9 years | |
| Randy Hubbell | M | 61 | 5 years | |
| Alain Philippart | M | - |
École des Hautes Études Commerciales de Paris
| 4 years |
| Soren Thestrup-Nielsen | M | - | 2 years | |
| Kamal Ramzipoor | M | - | 6 years | |
| Josh Baltzell | M | 55 | 6 years | |
| Michel Léonard | M | 72 |
École des Hautes Études Commerciales de Paris
| 4 years |
| Brad Pierce | M | - | 3 years | |
| Laurent Condomine | M | 79 |
École des Hautes Études Commerciales de Paris
| 1 years |
| Michel Picot | M | 72 |
École des Hautes Études Commerciales de Paris
| 4 years |
| George Harter | M | 67 | 5 years | |
| Matthew Jenusaitis | M | 63 | 2 years | |
| Robert Papin | M | 85 |
École des Hautes Études Commerciales de Paris
| 31 years |
| Michael Favet | M | 54 | 9 years | |
| Griffeth Tully | M | - | 8 years | |
| Jean-Marc Janaillac | M | 71 |
École des Hautes Études Commerciales de Paris
| 4 years |
| Michel Tabur | M | 75 |
École des Hautes Études Commerciales de Paris
| 4 years |
| Bertrand de Montesquiou | M | 76 |
École des Hautes Études Commerciales de Paris
| 4 years |
| Yu Te Chang | M | - | - | |
| Jacques Tierny | M | 70 |
École des Hautes Études Commerciales de Paris
| 4 years |
| Henri Saint-Olive | M | 81 |
École des Hautes Études Commerciales de Paris
| 4 years |
| Mark E. Bulmer | M | - | 10 years | |
| Jeannette Bankes | F | 53 | 15 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 45 | 45.00% |
| France | 29 | 29.00% |
| United Kingdom | 16 | 16.00% |
| Hong Kong | 12 | 12.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Michel Darnaud
- Personal Network
